Striving for Breakthroughs: First, Faster and for Patients

At AbbVie, we’re chasing bold goals. Investing in promising scientific discoveries and cutting-edge technology to develop life-changing medicines–and bring them to patients faster.


We seek cures and to pioneer breakthroughs

As scientific knowledge and technology advance at an incredible pace, we’re seizing the moment to unlock new solutions and possible cures.

Our research & development approach

Science and innovation are the lifeblood of our company. From drug discovery to clinical trials to regulatory approval, we're pursuing new ways to address patients' most challenging health issues.

Since our launch in 2013, we've invested more than $73 billion in R&D. This enables us to discover and deliver innovative medicines and products that solve serious health issues, enhance people's lives today, and address tomorrow's medical challenges.

We focus on core areas where our proven expertise and bold thinking have the greatest potential to solve unmet needs. These areas are oncology, immunology, neuroscience, eye care, medical aesthetics and other specialty areas.


People

To develop innovative medicines, you need innovative people. Our teams collaborate across disciplines to connect people and ideas, fueling a culture of curiosity and problem-solving.

Pipeline

Our R&D work fuels a dynamic and diverse pipeline that continues to advance and deliver medicines and solutions for patients.

Performance

The need to do more for patients motivates our R&D work. By investing in boundary-pushing approaches, we aim to advance programs with a stronger probability of success and move assets forward faster.

AbbVie’s research pipeline

At a glance: Pipeline highlights

Our R&D work fuels a dynamic and diverse pipeline that continues to advance and deliver new medicines and solutions for patients. Our pipeline includes 50 programs in mid- and late-stage development and 375+ clinical trials in 50+ countries.

Progress
~50
new molecular entities
Programs
75
+
clinical programs
impact
75
+
conditions treated
investment
$7.8
b
R&D investment in 2023

Thinking big to build a better future

Learn how our teams are striving to find cures, discover breakthroughs with advanced technology, and bring new medicines to patients faster.   

SEARCHING FOR CURES
Not good enough: behind the drive to give cancer patients more time
ADVANCING TECHNOLOGY
Three ways AI is changing drug discovery at AbbVie
Accelerating timelines
5 ways AbbVie is working to deliver medicines in half the time

Get Involved

Interested in joining our team of innovative scientists and researchers?